Genetix Introduces Two New “CloneMedia” Semi-Solid Media Reagents
17 January 2008
Genetix, a leading developer of technologies for automated, high throughput cell identification and selection for the pharmaceutical, biotechnology and clinical diagnostics industries, announces the expansion of its "CloneMedia" range of semi-solid media products for mammalian cell cloning. Launched at American Society of Cell Biology, in Washington DC, the two new products – CloneMedia-HEK and CloneMedia-CHOK1 – are designed for the semi-solid cloning of suspension-adapted, serum-free HEK293 and CHOK1 cells, respectively.
These two new CloneMedia products enable the cloning of transfected HEK293 and CHOK1 cell lines in a rapid, one-step system. Semi-solid media facilitate the growth of clonal colonies from single cells and subsequent isolation of high expressing clones within days of plating, thus eliminating the need for limiting dilutions.
Genetix cell biology reagents and consumables were designed for integration with ClonePix FL, Genetix's revolutionary system for rapid, automated cell identification, selection, isolation and collection, providing a complete system approach to cell biology applications. Manufactured to exceptional standards of quality, CloneMedia – and all Genetix cell biology reagents and consumables – are also highly effective and well-suited for use in manual cell identification and selection processes.
ABOUT GENETIX
Based in New Milton, UK, Genetix delivers pioneering, technological breakthroughs that give customers the competitive edge to find the cells and push the boundaries in biopharmaceutical and clinical research. Genetix offers the latest technologies for cell screening and selection, genetic testing and cancer pathology, protein science, microarraying, cell and liquid dispensing and a host of related reagents and consumables.
Genetix supplies major international Pharmaceutical and Biotechnology companies involved in the drug discovery process including GSK, Merck, Genentech, Wyeth, Novartis, as well as many leading academic institutions world-wide. The Company's achievements helped revolutionize cell biology, proteomics and genomics. It made a significant contribution to the Human Genome Project by supplying high-throughput equipment to seven of the leading eight laboratories of the consortium.
